These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Update on prevention of meningococcal disease: focus on tetravalent meningococcal conjugate vaccine. Mehlhorn AJ; Balcer HE; Sucher BJ Ann Pharmacother; 2006 Apr; 40(4):666-73. PubMed ID: 16595570 [TBL] [Abstract][Full Text] [Related]
29. Toward a meningitis-free world. Black S; Pizza M; Nissum M; Rappuoli R Sci Transl Med; 2012 Feb; 4(123):123ps5. PubMed ID: 22378923 [TBL] [Abstract][Full Text] [Related]
30. The changing epidemiology of meningococcal meningitis after introduction of bivalent A/C polysaccharide vaccine into school-based vaccination programs in Egypt. Nakhla I; Frenck RW; Teleb NA; El Oun S; Sultan Y; Mansour H; Mahoney F Vaccine; 2005 May; 23(25):3288-93. PubMed ID: 15837234 [TBL] [Abstract][Full Text] [Related]
31. [Neisseria meningitidis. The pathophysiological role of lipopolysaccharides in association with meningococcal disease and septic shock]. Pedersen MØ; Pedersen DS; Pedersen M; Penkowa M Ugeskr Laeger; 2008 Feb; 170(6):421-6. PubMed ID: 18252172 [TBL] [Abstract][Full Text] [Related]
32. [Meningococcal infections: aspects of microbiology, epidemiology and prevention]. Ehrhard I; Sonntag HG Gesundheitswesen; 1999 Oct; 61 Spec No 1():S41-5. PubMed ID: 10593044 [TBL] [Abstract][Full Text] [Related]
33. Immunization strategies for the control of serogroup C meningococcal disease in developed countries. De Wals P Expert Rev Vaccines; 2006 Apr; 5(2):269-75. PubMed ID: 16608426 [TBL] [Abstract][Full Text] [Related]
34. Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine--United States, June-July 2005. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2005 Oct; 54(40):1023-5. PubMed ID: 16224452 [TBL] [Abstract][Full Text] [Related]
35. Meningococcal C conjugate vaccine: the experience in England and Wales. Campbell H; Borrow R; Salisbury D; Miller E Vaccine; 2009 Jun; 27 Suppl 2():B20-9. PubMed ID: 19477053 [TBL] [Abstract][Full Text] [Related]
36. Quadrivalent meningococcal ACYW-135 glycoconjugate vaccine for broader protection from infancy. Pace D Expert Rev Vaccines; 2009 May; 8(5):529-42. PubMed ID: 19397410 [TBL] [Abstract][Full Text] [Related]
37. [Neisseria meningitidis and meningitis]. Nicolas P; Debonne JM; Martet G Med Trop (Mars); 1999; 59(1):68-78. PubMed ID: 10472587 [TBL] [Abstract][Full Text] [Related]
38. Preventing meningococcal infection in college students. Harrison LH Clin Infect Dis; 2000 Apr; 30(4):648-51. PubMed ID: 10770724 [TBL] [Abstract][Full Text] [Related]
39. Risk factors for meningococcal disease in students in grades 9-12. Harrison LH; Kreiner CJ; Shutt KA; Messonnier NE; O'Leary M; Stefonek KR; Lin H; Lynfield R; Barrett NL; Arnold KE; Jones TF; Montero JT; Pediatr Infect Dis J; 2008 Mar; 27(3):193-9. PubMed ID: 18277925 [TBL] [Abstract][Full Text] [Related]
40. [Critical review of control strategies for meningococcal meningitis epidemics in Sub-Saharan Africa]. Chippaux JP; Debois H; Saliou P Bull Soc Pathol Exot; 2002 Mar; 95(1):37-44. PubMed ID: 12012963 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]